CHI Advisors as of June 30, 2023
Portfolio Holdings for CHI Advisors
CHI Advisors holds 25 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pliant Therapeutics (PLRX) | 17.7 | $59M | 3.2M | 18.12 | |
| Acelyrin | 16.8 | $56M | 2.7M | 20.90 | |
| Vectivbio Hldg Ord Shs | 14.2 | $47M | 2.8M | 16.87 | |
| Cullinan Oncology (CGEM) | 11.1 | $37M | 3.4M | 10.76 | |
| Repare Therapeutics Ord (RPTX) | 9.6 | $32M | 3.0M | 10.58 | |
| Keros Therapeutics (KROS) | 4.9 | $16M | 402k | 40.18 | |
| Ikena Oncology (IKNA) | 4.2 | $14M | 2.1M | 6.56 | |
| Compass Therapeutics (CMPX) | 2.7 | $9.0M | 2.8M | 3.18 | |
| Larimar Therapeutics (LRMR) | 2.6 | $8.7M | 3.4M | 2.55 | |
| 2seventy Bio Common Stock | 2.6 | $8.6M | 852k | 10.12 | |
| Inozyme Pharma (INZY) | 2.0 | $6.7M | 1.2M | 5.57 | |
| Omega Therapeutics Common Stock (OMGAQ) | 1.8 | $5.9M | 1.1M | 5.60 | |
| Disc Medicine (IRON) | 1.7 | $5.6M | 125k | 44.40 | |
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 1.4 | $4.7M | 325k | 14.37 | |
| Orchard Therapeutics Spon Ads New | 1.2 | $3.9M | 756k | 5.21 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $3.9M | 85k | 46.13 | |
| Black Diamond Therapeutics (BDTX) | 1.1 | $3.8M | 750k | 5.05 | |
| Rallybio Corp (RLYB) | 0.9 | $3.1M | 543k | 5.66 | |
| Ovid Therapeutics (OVID) | 0.9 | $2.8M | 865k | 3.28 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.7 | $2.4M | 767k | 3.15 | |
| Precision Biosciences Ord | 0.3 | $844k | 1.6M | 0.53 | |
| Hookipa Pharma Inc equity | 0.2 | $694k | 789k | 0.88 | |
| Graphite Bio | 0.2 | $600k | 231k | 2.60 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $458k | 200k | 2.29 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.0 | $56k | 22k | 2.58 |
